A Prospective, Multicentre, Open-Label Single-Arm Exploratory Study to Evaluate Efficacy and Safety of Saroglitazar on Hypertriglyceridemia in HIV Associated Lipodystrophy.
about
Quantitative determination of saroglitazar, a predominantly PPAR alpha agonist, in human plasma by a LC-MS/MS method utilizing electrospray ionization in a positive mode.PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part I: PPAR-α.The Positive Regulation of eNOS Signaling by PPAR Agonists in Cardiovascular Diseases.
P2860
A Prospective, Multicentre, Open-Label Single-Arm Exploratory Study to Evaluate Efficacy and Safety of Saroglitazar on Hypertriglyceridemia in HIV Associated Lipodystrophy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A Prospective, Multicentre, Op ...... HIV Associated Lipodystrophy.
@ast
A Prospective, Multicentre, Op ...... HIV Associated Lipodystrophy.
@en
type
label
A Prospective, Multicentre, Op ...... HIV Associated Lipodystrophy.
@ast
A Prospective, Multicentre, Op ...... HIV Associated Lipodystrophy.
@en
prefLabel
A Prospective, Multicentre, Op ...... HIV Associated Lipodystrophy.
@ast
A Prospective, Multicentre, Op ...... HIV Associated Lipodystrophy.
@en
P2093
P2860
P1433
P1476
A Prospective, Multicentre, Op ...... HIV Associated Lipodystrophy.
@en
P2093
Alka Deshpande
Harsh Toshniwal
Shashank Joshi
P2860
P304
P356
10.1371/JOURNAL.PONE.0146222
P407
P577
2016-01-20T00:00:00Z